Cellular neurothekeoma is driven by copy number deletions, providing potential diagnostic and therapeutic avenues

To date our knowledge of the genomic landscape of cellular neurothekeoma (cNTK) remains incomplete. Thus, in order to comprehensively elucidate the mutational profile of this rare tumour type and identify driver events, we sequenced DNA (whole-exome sequencing) and RNA (pulldown transcriptome) from an international, multi-institutional cohort of cNTK tumour-normal pairs (n = 20). We identified copy number (CN) alterations as a driver event of this tumour type, with the most recurrent CN alteration being a deletion on 9p21.3 that encompassed MTAP and the C-terminal exons of CDKN2A.

Authors

Institutions

Publication Details

Journal
British Journal of Dermatology
Published
2025-12-06
DOI
https://doi.org/10.1093/bjd/ljaf487
Citations
1
Primary Topic
Neurofibromatosis and Schwannoma Cases
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cellular neurothekeoma is driven by copy number deletions, providing potential diagnostic and therapeutic avenues

Thomas Brenn, Emily L. Clarke, Saamin Cheema, Mark J. Arends et al.
1 citations
British Journal of Dermatology
Neurofibromatosis and Schwannoma Cases
1.39
article

Cellular neurothekeoma is driven by copy number deletions, providing potential diagnostic and therapeutic avenues

Thomas Brenn, Emily L. Clarke, Saamin Cheema, Mark J. Arends, Ian Vermes, Martin Del Castillo Velasco‐Herrera, Louise van der Weyden, Steven D. Billings, Carlos Couceiro Monteagudo, Katharina Wiedemeyer, Ingrid Ferreira, Paul W. Harms, Annie Cristhine Moraes Sousa‐Squiavinato, Kim Wong, Maximillian A. Weigelt, Ahmed Al‐Omari, Elizabeth Anderson, David J. Adams, William Merchant, Jamie Billington, Anshul Vasisht
article en
1 citations

Abstract

To date our knowledge of the genomic landscape of cellular neurothekeoma (cNTK) remains incomplete. Thus, in order to comprehensively elucidate the mutational profile of this rare tumour type and identify driver events, we sequenced DNA (whole-exome sequencing) and RNA (pulldown transcriptome) from an international, multi-institutional cohort of cNTK tumour-normal pairs (n = 20). We identified copy number (CN) alterations as a driver event of this tumour type, with the most recurrent CN alteration being a deletion on 9p21.3 that encompassed MTAP and the C-terminal exons of CDKN2A.

British Journal of DermatologyVol. 194(3)
University of Leeds (GB), Cleveland Clinic (US), Universitat de València (ES), University of Michigan (US), Leeds Teaching Hospitals NHS Trust (GB), Wellcome Sanger Institute (GB), Edinburgh Cancer Research (GB), Biomedical Research Institute (US), INCLIVA Health Research Institute (ES), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US)
Openalex Percentile: Top 13%
Neurofibromatosis and Schwannoma Cases
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.